Skip to main content
CBLL logo

CeriBell, Inc.

CBLLNASDAQHealthcareMedical Devices

$27.22Today:- (-)1Y +111.75%

As of Oct 27, 2026 close

Market cap
$1.04B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$10.85$27.94
Volume (live)
-
Avg. volume (3M)
458.88K

CeriBell (CBLL) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), CeriBell used $40.81M of cash in operating activities and spent $767.00K on capital expenditures. That left free cash flow of −$41.58M.

CeriBell Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for CeriBell, Inc. (CBLL) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022
Period endingDec 2025Dec 2024Dec 2023Dec 2022
Operating Activities
Net Income-53.41-40.46-29.46-37.16
Depreciation & Amortization-0.671.140.850.50
Stock Based Compensation12.225.412.687.93
Change in Working Capital0.63-3.17-3.70-3.88
Change in Accounts Receivable-4.18-3.51-2.66-3.06
Change in Inventory-0.35-1.07-1.79-1.90
Change in Accounts Payable1.750.250.310.12
Change in Other Working Capital3.411.160.34-1.13
Other Operating Activities0.422.030.340.62
Net Cash from Operating Activities-40.81-35.04-29.16-32.00
Investing Activities
Capital Expenditures-0.77-1.34-0.98-1.40
Purchases of Investments-210.820.000.000.00
Sales/Maturities of Investments94.200.000.000.00
Other Investing Activities-0.76-0.26-0.78-0.88
Net Cash from Investing Activities-118.14-1.60-1.76-1.40
Financing Activities
Debt Repayment0.007.91-3.75-0.04
Common Stock Issued5.44188.920.930.15
Other Financing Activities-0.39-0.300.93-0.31
Net Cash from Financing Activities5.05196.52-2.8249.81
Summary
Net Change in Cash-153.89159.88-33.7416.40
Cash at Beginning of Period194.3734.5068.2451.83
Cash at End of Period40.48194.3734.5068.24
Free Cash Flow-41.58-36.38-30.14-33.40
Supplemental Disclosures
Interest Paid-1.951.731.63

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About CeriBell Cash Flow

What is CeriBell's free cash flow?

CeriBell had negative free cash flow of $41.58M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$40.81M minus $767.00K of capital expenditures.

How much does CeriBell spend on capital expenditures?

CeriBell spent $767.00K on capital expenditures in fiscal 2025, compared with $1.34M a year earlier.

Does CeriBell pay dividends or buy back shares?

CeriBell's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition